Lidocaine Infusion for Propofol Dose Reduction in ERCP Procedure
Status:
Recruiting
Trial end date:
2022-04-03
Target enrollment:
Participant gender:
Summary
This study aims to investigate the dose reduction of propofol if associated with continuous
infusion of lidocaine during ERCP procedures in patients over 65 years old.
Phase:
Phase 1
Details
Lead Sponsor:
Iuliu Hatieganu University of Medicine and Pharmacy